BNP Paribas Asset Management’s BioNTech BNTX Stock Holding History
Bought
Maintained
Sold
Other funds holding BNTX
LGM
GP
BNP Paribas Asset Management's BNTX Position: Q2 2026 in Review
BNP Paribas Asset Management reduced its BioNTech (BNTX) stake by 5.2% in Q2 2026, selling an estimated $465K and leaving 90,616 shares worth $8.43M. The position accounts for 0.01% of the portfolio, ranked #770.
BNP Paribas Asset Management first reported a position in BNTX in Q4 2021 and has held it in 18 quarters since. The position peaked at $9.06M in Q4 2025. 282 funds tracked by Wall St. Rank hold BNTX as of Q2 2026.
- BNP Paribas Asset Management held 90,616 shares of BioNTech worth $8.43M as of Q2 2026.
- BNP Paribas Asset Management sold 4,942 BioNTech shares in Q2 2026, an estimated $465K.
- BioNTech made up 0.01% of BNP Paribas Asset Management's portfolio in Q2 2026, its #770 holding.
- BNP Paribas Asset Management first reported a position in BioNTech in Q4 2021 and has held it in 18 quarters since.
- BNP Paribas Asset Management's BioNTech position peaked at $9.06M in Q4 2025.
- 282 funds tracked by Wall St. Rank held BioNTech as of Q2 2026.
Based on BNP Paribas Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.